Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancer

This publication has 47 references indexed in Scilit:

• Recent advances in management of small-cell lung cancer
  Cancer Treatment Reviews, 2004
• Synergistic Induction of Oxidative Injury and Apoptosis in Human Multiple Myeloma Cells by the Proteasome Inhibitor Bortezomib and Histone Deacetylase Inhibitors
  Clinical Cancer Research, 2004
• To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis
  Oncogene, 2003
• The function of multiple IκB : NF-κB complexes in the resistance of cancer cells to Taxol-induced apoptosis
  Oncogene, 2002
• The Bcl2 family: regulators of the cellular life-or-death switch
  Nature Reviews Cancer, 2002
• Small Cell Lung Cancer: Current Therapy and Promising New Regimens
  The Oncologist, 2002
• Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer
  Oncogene, 2001
• Bcl-2 family proteins as targets for anticancer drug design
  Oncogene, 2000
• Bcl-2 Oncoprotein Expression Is Increased Especially in the Portion of Small Cell Carcinoma within the Combined Type of Small Cell Lung Cancer
  Tumor Biology, 1996
• Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance
  Current Opinion in Oncology, 1995